John Cunningham | White & Case LLP International Law Firm, Global Law Practice
John Cunningham
John Cunningham

John Cunningham

Partner, London

T +44 20 7532 2199

T +44 20 7532 1000

E johncunningham@whitecase.com

A corporate finance partner with extensive experience of the infrastructure and healthcare sectors.

Overview

John Cunningham's clients benefit from his wide-ranging domestic and cross-border experience in public and private mergers and acquisitions, disposals and joint ventures, with a particular focus in the infrastructure and healthcare sectors.

John has advised corporates, banks, private equity houses and funds on a multitude of complex cross-border transactions. He counts a number of high-profile deals among his successes, including, in the infrastructure space, RWE AG's €1.6 billion disposal of NET4GAS and EPH's acquisition of Eggborough Power Plant, and in the healthcare sector, Bupa's acquisition of Poland's leading healthcare provider.

During his career, John spent nine months on secondment to GlaxoSmithKline's legal department, spending time in the UK and US working on a wide variety of matters, with a particular focus on M&A and global procurement.

Bars and Courts

  • England and Wales

Education

  • LPC, College of Law, London
  • CPE, College of Law, London
  • BA, Oxford University

Languages

  • English
  • French

Experience

Wren House's acquisition of stake in GPG

Represented Wren House, the infrastructure investment arm of the Kuwait Investment Authority, on its acquisition of a 25% stake in GNF's global power generation portfolio, GPG.

EPH's acquisition of Eggborough power station, 2014

Represented Energetický a průmyslový holding (EPH) in its agreement to buy Eggborough power station in North Yorkshire from a consortium led by Strategic Value Partners.

Limak's €285 million disposal, 2014

Represented Limak in the €285 million sale of its 40% stake in Istanbul’s Sabiha Gokcen International Airport to Malaysia Airports Holdings Bhd.

Alpha Trains' purchase of a rolling stock portfolio, 2013

Represented Alpha Trains in the acquisition of 202 Pan-European rolling stock assets from the Royal Bank of Scotland, in a combined asset and share sale transaction. The deal was particularly complex, since the assets are operational across 12 European jurisdictions.

Novartis investment in Oxford Biomedica plc, 2014

Represented Novartis in its USD$14 million collaboration with Oxford Biomedica including LentiVector® licence agreement.

RWE's €1.6 billion disposal, 2013

Represented RWE AG in the €1.6 billion sale of NET4GAS, s.r.o., the Czech gas transmission system operator, to a consortium of Allianz Capital Partners and Borealis Infrastructure Management Inc, the Canada-based infrastructure arm of OMERS.

Bupa's €400 million acquisition of LuxMed, 2012

Advised Bupa, the international healthcare and health insurance group, on its €400 million acquisition of LUXMED Group, Poland's largest private healthcare services provider, from Mid Europa Partners.

Autostrade per l’Italia’s partial disposal in Chile, 2012

Acted for Autostrade per l'Italia, a subsidiary of Italian motorway operator Atlantia, on the €857 million (US$1.13 billion) sale of a 49.99 percent stake in Grupo Costanera, its Chilean unit - which owns five toll roads in Chile - to the Canada Pension Plan Investment Board.

Seabed to surface engineering merger, 2011

Represented NASDAQ- and Oslo Stock Exchange-listed Acergy S.A. in its combination with Oslo Stock Exchange-listed Subsea 7 Inc., to create a US$8.8 billion global leader in seabed-to-surface engineering and construction.

Awards & Recognition

Emerging Leaders Awards winner, M&A Advisor, 2015